PULSE BIOSCIENCES, INC.

HAYWARD, CA · Founded 2014 · CIK 0001625101 · Medtech · Public

Endoscopic ultrasound-guided bipolar catheter delivering nanosecond electric pulses and immunostimulant injection to pancreatic tumors

Grants
$303K
1 award
Sector median: 1
Raised
$93M
4 Form D · Jul 2021
63 months since last filing
Contracts
—
No federal contracts on record
Patents
40
18 granted · 22 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$7,999,997
Private capital raisedForm D · SEC$5,000,005
Private capital raisedForm D · SEC$30,040,000
Private capital raisedForm D · SEC$50,000,000
Federal grantDepartment of Health and Human Services · Phase I · Minimally invasive pancreatic cancer treatment combining nanosecond electric pulses and immune system stimulants$303,475
Federal grant · SBIR/STTRForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1169Optilume Stricture, LLC—$954K
1170Instanosis, Inc.——
1171OSCILLOSCAPE, LLC—$165K
1172PULSE BIOSCIENCES, INC.—$93M
1173Epica International, Inc.—$19M
1174Houston Medical Robotics, Inc.—$87K
1175Swift Medical Inc.—$23M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 16 related persons
  • Kenneth ClarkDirector
  • Brian DowExecutive Officer
  • Robert DugganDirector
  • Edward EbbersExecutive Officer
  • Sandra GardinerExecutive Officer
  • Robert GreenbergDirector
  • Robert LevandeDirector · Executive Officer · Promoter
  • Mitchell LevinsonDirector
  • Christopher MarlettDirector
  • Manmeet SoniDirector
  • Thierry ThaureDirector
  • Darrin UeckerDirector · Executive Officer
  • Richard van den BroekDirector
  • Amy WangDirector · Executive Officer
  • Mahkam ZanganehDirector
  • Maky ZanganehDirector

Patents

USPTO · 18 granted of 40

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.